1. Home
  2. HSDT vs SGBX Comparison

HSDT vs SGBX Comparison

Compare HSDT & SGBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HSDT
  • SGBX
  • Stock Information
  • Founded
  • HSDT 2014
  • SGBX 2007
  • Country
  • HSDT United States
  • SGBX United States
  • Employees
  • HSDT N/A
  • SGBX N/A
  • Industry
  • HSDT Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • SGBX RETAIL: Building Materials
  • Sector
  • HSDT Health Care
  • SGBX Consumer Discretionary
  • Exchange
  • HSDT Nasdaq
  • SGBX Nasdaq
  • Market Cap
  • HSDT 1.8M
  • SGBX 2.1M
  • IPO Year
  • HSDT N/A
  • SGBX 2017
  • Fundamental
  • Price
  • HSDT $0.49
  • SGBX $0.62
  • Analyst Decision
  • HSDT Buy
  • SGBX
  • Analyst Count
  • HSDT 2
  • SGBX 0
  • Target Price
  • HSDT $24.00
  • SGBX N/A
  • AVG Volume (30 Days)
  • HSDT 116.7K
  • SGBX 3.9M
  • Earning Date
  • HSDT 11-12-2024
  • SGBX 11-26-2024
  • Dividend Yield
  • HSDT N/A
  • SGBX N/A
  • EPS Growth
  • HSDT N/A
  • SGBX N/A
  • EPS
  • HSDT N/A
  • SGBX N/A
  • Revenue
  • HSDT $502,000.00
  • SGBX $8,193,436.00
  • Revenue This Year
  • HSDT $16.41
  • SGBX $273.79
  • Revenue Next Year
  • HSDT $31.97
  • SGBX $39.31
  • P/E Ratio
  • HSDT N/A
  • SGBX N/A
  • Revenue Growth
  • HSDT N/A
  • SGBX N/A
  • 52 Week Low
  • HSDT $0.37
  • SGBX $0.50
  • 52 Week High
  • HSDT $9.50
  • SGBX $20.20
  • Technical
  • Relative Strength Index (RSI)
  • HSDT 48.71
  • SGBX 31.30
  • Support Level
  • HSDT $0.44
  • SGBX $0.50
  • Resistance Level
  • HSDT $0.58
  • SGBX $0.76
  • Average True Range (ATR)
  • HSDT 0.05
  • SGBX 0.17
  • MACD
  • HSDT 0.01
  • SGBX -0.04
  • Stochastic Oscillator
  • HSDT 42.65
  • SGBX 8.95

About HSDT Helius Medical Technologies Inc. (DE)

Helius Medical Technologies Inc is a neurotech company focused on neurological wellness. The company's purpose is to develop, license, or acquire non-invasive technologies targeted at reducing symptoms of neurological disease or trauma. The company's product, known as the Portable Neuromodulation Stimulator (PoNS), is authorized for sale in Canada as a class II, a non-implantable medical device intended for use as a short-term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury and is to be used in conjunction with supervised therapeutic exercise.

About SGBX Safe & Green Holdings Corp.

Safe & Green Holdings Corp is a modular solutions company. The company currently provides modules made out of both code-engineered cargo shipping containers and wood for use as both permanent or temporary structures for residential housing use and commercial use, including for health care facilities. It operates in four segments: construction services; medical; real estate development; and environmental. The company generates the majority of its revenue from the Construction segment includes the company's manufacturing unit SG ECHO and other modules projects.

Share on Social Networks: